| 000 | 01315 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511131931.0 | ||
| 264 | 0 | _c19900503 | |
| 008 | 199005s 0 0 eng d | ||
| 022 | _a0011-5029 | ||
| 024 | 7 |
_a10.1016/s0011-5029(78)80004-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHorstmann, D M | |
| 245 | 0 | 0 |
_aProblems in measles and rubella. _h[electronic resource] |
| 260 |
_bDisease-a-month : DM _cMar 1978 |
||
| 300 |
_a1-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity, Innate |
| 650 | 0 | 4 | _aImmunization, Passive |
| 650 | 0 | 4 | _aImmunization, Secondary |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aMeasles _xepidemiology |
| 650 | 0 | 4 |
_aMeasles Vaccine _xtherapeutic use |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications, Infectious _xprevention & control |
| 650 | 0 | 4 |
_aRubella _xepidemiology |
| 650 | 0 | 4 |
_aRubella Vaccine _xtherapeutic use |
| 650 | 0 | 4 | _aVaccines, Attenuated |
| 773 | 0 |
_tDisease-a-month : DM _gvol. 24 _gno. 6 _gp. 1-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0011-5029(78)80004-2 _zAvailable from publisher's website |
| 999 |
_c422128 _d422128 |
||